Efficacy of Continuous Lateral Rotation Therapy in Mechanically Ventilated Critically Ill Adults on Clinical Outcomes

医学 随机对照试验 机械通风 重症监护室 荟萃分析 呼吸机相关性肺炎 梅德林 奇纳 重症监护 肺炎 重症监护医学 内科学 心理干预 政治学 精神科 法学
作者
Anna Luísa Araújo Brito,A. Ferreira,LAYANE SANTANA PEREIRA COSTA,Emanuel F. F. Silva Júnior,Shirley Lima Campos
出处
期刊:Respiratory Care [American Association for Respiratory Care]
卷期号:69 (12): 1592-1606
标识
DOI:10.4187/respcare.11781
摘要

Background: This PICO-guided systematic review assessed continuous lateral rotation therapy (CLRT) versus conventional position changes in mechanically ventilated critically ill adults, evaluating mortality, intensive care unit (ICU) and hospital stay duration as primary outcomes, and respiratory function, mechanical ventilation duration, pulmonary complications, and adverse events, as secondary outcomes. Methods: A systematic review followed PRISMA criteria (PROSPERO CRD42022384258). Searches spanned databases: MEDLINE/PubMed, EMBASE, Scopus, ScienceDirect, Cochrane, CINAHL and Web of Science, without language or publication year restrictions. Inclusion criteria involved randomized (RCT) and quasi-randomized trials, comparing CLRT (intervention) with conventional position changes (control). Risk of bias and quality of evidence for RCTs were assessed using the Cochrane collaboration and GRADE tools. For the quasi-randomized trials, the ROBINS-I tool was used. Results: In 18 studies with 1.466 participants (intervention, n= 700, 47.7%; control, n= 766, 52.2%), CLRT was predominantly used for prophylactic purposes, with protocols varying from 10 to 24 hours/day. Meta-analysis (16 RCTs) favored CLRT for reduced mechanical ventilation duration (SMD -0.17 days, CI -0.29 to -0.04, p=0.008) and lower nosocomial pneumonia incidence (OR 0.39, CI 0.29 to 0.52, p<0.00001). CLRT showed no significant impact on mortality (OR 1.04, CI 0.80 to 1.34, p= 0.77), ICU stay (SMD -0.11 days, CI -0.25 to 0.02, p= 0.11), hospital stay (SMD -0.10 days, CI -0.31 to 0.11, p= 0.33) and incidence of pressure ulcers (OR 0.73, CI 0,34 to 1.60, p= 0.44). Conclusions: CLRT showed no significant difference in primary outcomes (mortality, ICU, and hospital stay duration) but revealed significant differences in secondary outcomes (consistently reduced nosocomial pneumonia, with a minor effect on MV duration), supported by moderate certainty. Very low certainty for other outcomes highlights the need for current studies in diverse clinical settings and protocols to assess CLRT effectiveness.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
计算小凡完成签到 ,获得积分10
刚刚
周周周周Jared完成签到,获得积分10
刚刚
hhh完成签到,获得积分20
1秒前
1秒前
5秒前
杜胤江完成签到,获得积分10
5秒前
无奈寒梦完成签到,获得积分10
5秒前
微光发布了新的文献求助10
6秒前
7秒前
yudandan@CJLU发布了新的文献求助10
7秒前
骑乌龟上高速完成签到,获得积分10
7秒前
坦率的语柳完成签到 ,获得积分10
7秒前
shenren完成签到,获得积分10
7秒前
SciGPT应助666采纳,获得10
8秒前
坦率曼梅完成签到,获得积分10
8秒前
xiaoliu完成签到,获得积分10
8秒前
乱泽华完成签到,获得积分10
9秒前
scx发布了新的文献求助10
9秒前
9秒前
11秒前
桃桃淘完成签到,获得积分10
11秒前
励志发顶刊完成签到,获得积分10
12秒前
叶光大完成签到 ,获得积分10
12秒前
外向的凝阳完成签到 ,获得积分10
13秒前
13秒前
13秒前
13秒前
Orange应助科研通管家采纳,获得10
13秒前
星辰大海应助科研通管家采纳,获得10
13秒前
FashionBoy应助科研通管家采纳,获得10
13秒前
Lucas应助科研通管家采纳,获得10
13秒前
小蘑菇应助科研通管家采纳,获得10
13秒前
小天应助科研通管家采纳,获得30
14秒前
NexusExplorer应助科研通管家采纳,获得10
14秒前
阿尔维斯完成签到,获得积分20
14秒前
正弦交流电完成签到,获得积分20
14秒前
15秒前
15秒前
狂野的靖雁完成签到 ,获得积分10
16秒前
阿曾完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Photodetectors: From Ultraviolet to Infrared 500
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6359333
求助须知:如何正确求助?哪些是违规求助? 8173297
关于积分的说明 17214088
捐赠科研通 5414460
什么是DOI,文献DOI怎么找? 2865441
邀请新用户注册赠送积分活动 1842803
关于科研通互助平台的介绍 1691020